<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:01a0f6f1-5e71-7cb8-9069-eb23ed455234,g:392af1d3-d3ef-4849-a1da-b622b127d3e1-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:teva="http://www.tevapharm.com/20260930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.tevapharm.com/20260930">
  <xs:import namespace="http://fasb.org/srt/2026" schemaLocation="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2026" schemaLocation="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2026" schemaLocation="https://xbrl.sec.gov/country/2026/country-2026.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2026" schemaLocation="https://xbrl.sec.gov/dei/2026/dei-2026.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2026" schemaLocation="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="teva-20260930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="teva-20260930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="teva-20260930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="teva-20260930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.tevapharm.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.tevapharm.com/role/ConsolidatedBalanceSheets">
        <link:definition>9952151 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.tevapharm.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>9952152 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofIncomeLoss" roleURI="http://www.tevapharm.com/role/ConsolidatedStatementsofIncomeLoss">
        <link:definition>9952153 - Statement - Consolidated Statements of Income (Loss)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveIncomeLoss" roleURI="http://www.tevapharm.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss">
        <link:definition>9952154 - Statement - Consolidated Statements of Comprehensive Income (Loss)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofChangesinEquity" roleURI="http://www.tevapharm.com/role/ConsolidatedStatementsofChangesinEquity">
        <link:definition>9952155 - Statement - Consolidated Statements of Changes in Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.tevapharm.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>9952156 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Basisofpresentation" roleURI="http://www.tevapharm.com/role/Basisofpresentation">
        <link:definition>9952157 - Disclosure - Basis of presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Certaintransactions" roleURI="http://www.tevapharm.com/role/Certaintransactions">
        <link:definition>9952158 - Disclosure - Certain transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Revenuefromcontractswithcustomers" roleURI="http://www.tevapharm.com/role/Revenuefromcontractswithcustomers">
        <link:definition>9952159 - Disclosure - Revenue from contracts with customers</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Inventories" roleURI="http://www.tevapharm.com/role/Inventories">
        <link:definition>9952160 - Disclosure - Inventories</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Identifiableintangiblesssets" roleURI="http://www.tevapharm.com/role/Identifiableintangiblesssets">
        <link:definition>9952161 - Disclosure - Identifiable intangible sssets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Goodwill" roleURI="http://www.tevapharm.com/role/Goodwill">
        <link:definition>9952162 - Disclosure - Goodwill</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debtobligations" roleURI="http://www.tevapharm.com/role/Debtobligations">
        <link:definition>9952163 - Disclosure - Debt obligations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Derivativeinstrumentsandhedgingactivities" roleURI="http://www.tevapharm.com/role/Derivativeinstrumentsandhedgingactivities">
        <link:definition>9952164 - Disclosure - Derivative instruments and hedging activities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Legalsettlementsandlosscontingencies" roleURI="http://www.tevapharm.com/role/Legalsettlementsandlosscontingencies">
        <link:definition>9952165 - Disclosure - Legal settlements and loss contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Commitmentsandcontingencies" roleURI="http://www.tevapharm.com/role/Commitmentsandcontingencies">
        <link:definition>9952166 - Disclosure - Commitments and contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Incometaxes" roleURI="http://www.tevapharm.com/role/Incometaxes">
        <link:definition>9952167 - Disclosure - Income taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Otherassetsimpairmentsrestructuringandotheritems" roleURI="http://www.tevapharm.com/role/Otherassetsimpairmentsrestructuringandotheritems">
        <link:definition>9952168 - Disclosure - Other assets impairments, restructuring and other items</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Earningslosspershare" roleURI="http://www.tevapharm.com/role/Earningslosspershare">
        <link:definition>9952169 - Disclosure - Earnings (loss) per share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Accumulatedothercomprehensiveincomeloss" roleURI="http://www.tevapharm.com/role/Accumulatedothercomprehensiveincomeloss">
        <link:definition>9952170 - Disclosure - Accumulated other comprehensive income (loss)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Segments" roleURI="http://www.tevapharm.com/role/Segments">
        <link:definition>9952171 - Disclosure - Segments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Fairvaluemeasurement" roleURI="http://www.tevapharm.com/role/Fairvaluemeasurement">
        <link:definition>9952172 - Disclosure - Fair value measurement</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofpresentationPolicies" roleURI="http://www.tevapharm.com/role/BasisofpresentationPolicies">
        <link:definition>9955511 - Disclosure - Basis of presentation (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CertaintransactionsTables" roleURI="http://www.tevapharm.com/role/CertaintransactionsTables">
        <link:definition>9955512 - Disclosure - Certain transactions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuefromcontractswithcustomersTables" roleURI="http://www.tevapharm.com/role/RevenuefromcontractswithcustomersTables">
        <link:definition>9955513 - Disclosure - Revenue from contracts with customers (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesTables" roleURI="http://www.tevapharm.com/role/InventoriesTables">
        <link:definition>9955514 - Disclosure - Inventories (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IdentifiableintangibleassetsTables" roleURI="http://www.tevapharm.com/role/IdentifiableintangibleassetsTables">
        <link:definition>9955515 - Disclosure - Identifiable intangible assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillTables" roleURI="http://www.tevapharm.com/role/GoodwillTables">
        <link:definition>9955516 - Disclosure - Goodwill (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtobligationsTables" roleURI="http://www.tevapharm.com/role/DebtobligationsTables">
        <link:definition>9955517 - Disclosure - Debt obligations (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeinstrumentsandhedgingactivitiesTables" roleURI="http://www.tevapharm.com/role/DerivativeinstrumentsandhedgingactivitiesTables">
        <link:definition>9955518 - Disclosure - Derivative instruments and hedging activities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherassetsimpairmentsrestructuringandotheritemsTables" roleURI="http://www.tevapharm.com/role/OtherassetsimpairmentsrestructuringandotheritemsTables">
        <link:definition>9955519 - Disclosure - Other assets impairments, restructuring and other items (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningslosspershareTables" roleURI="http://www.tevapharm.com/role/EarningslosspershareTables">
        <link:definition>9955520 - Disclosure - Earnings (loss) per share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedothercomprehensiveincomelossTables" roleURI="http://www.tevapharm.com/role/AccumulatedothercomprehensiveincomelossTables">
        <link:definition>9955521 - Disclosure - Accumulated other comprehensive income (loss) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsTables" roleURI="http://www.tevapharm.com/role/SegmentsTables">
        <link:definition>9955522 - Disclosure - Segments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairvaluemeasurementTables" roleURI="http://www.tevapharm.com/role/FairvaluemeasurementTables">
        <link:definition>9955523 - Disclosure - Fair value measurement (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CertaintransactionsAcquisitionsNarrativeDetails" roleURI="http://www.tevapharm.com/role/CertaintransactionsAcquisitionsNarrativeDetails">
        <link:definition>9955524 - Disclosure - Certain transactions - Acquisitions Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CertaintransactionsScheduleofAssetAcquisitionDetails" roleURI="http://www.tevapharm.com/role/CertaintransactionsScheduleofAssetAcquisitionDetails">
        <link:definition>9955525 - Disclosure - Certain transactions - Schedule of Asset Acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CertaintransactionsOtherSignificantAgreementsNarrativeDetail" roleURI="http://www.tevapharm.com/role/CertaintransactionsOtherSignificantAgreementsNarrativeDetail">
        <link:definition>9955526 - Disclosure - Certain transactions - Other Significant Agreements Narrative (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CertaintransactionsOtherSignificantAgreementsNarrativeDetail_1" roleURI="http://www.tevapharm.com/role/CertaintransactionsOtherSignificantAgreementsNarrativeDetail_1">
        <link:definition>9955526 - Disclosure - Certain transactions - Other Significant Agreements Narrative (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CertaintransactionsAssetsandLiabilitiesHeldforSaleDetails" roleURI="http://www.tevapharm.com/role/CertaintransactionsAssetsandLiabilitiesHeldforSaleDetails">
        <link:definition>9955527 - Disclosure - Certain transactions - Assets and Liabilities Held for Sale (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CertaintransactionsSummaryofMajorClassesofAssetsandLiabilitiesIncludedasHeldforSaleDetail" roleURI="http://www.tevapharm.com/role/CertaintransactionsSummaryofMajorClassesofAssetsandLiabilitiesIncludedasHeldforSaleDetail">
        <link:definition>9955528 - Disclosure - Certain transactions - Summary of Major Classes of Assets and Liabilities Included as Held for Sale (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuefromcontractswithcustomersSummaryofDisaggregationofRevenuesbyMajorRevenueStreamsDetail" roleURI="http://www.tevapharm.com/role/RevenuefromcontractswithcustomersSummaryofDisaggregationofRevenuesbyMajorRevenueStreamsDetail">
        <link:definition>9955529 - Disclosure - Revenue from contracts with customers - Summary of Disaggregation of Revenues by Major Revenue Streams (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuefromcontractswithcustomersAdditionalInformationDetail" roleURI="http://www.tevapharm.com/role/RevenuefromcontractswithcustomersAdditionalInformationDetail">
        <link:definition>9955530 - Disclosure - Revenue from contracts with customers - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuefromcontractswithcustomersScheduleofSalesReservesandAllowancesDetail" roleURI="http://www.tevapharm.com/role/RevenuefromcontractswithcustomersScheduleofSalesReservesandAllowancesDetail">
        <link:definition>9955531 - Disclosure - Revenue from contracts with customers - Schedule of Sales Reserves and Allowances (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesSummaryofInventoriesDetail" roleURI="http://www.tevapharm.com/role/InventoriesSummaryofInventoriesDetail">
        <link:definition>9955532 - Disclosure - Inventories - Summary of Inventories (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IdentifiableintangibleassetsSummaryofIdentifiableIntangibleAssetsDetail" roleURI="http://www.tevapharm.com/role/IdentifiableintangibleassetsSummaryofIdentifiableIntangibleAssetsDetail">
        <link:definition>9955533 - Disclosure - Identifiable intangible assets - Summary of Identifiable Intangible Assets (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IdentifiableintangibleassetsAdditionalInformationDetail" roleURI="http://www.tevapharm.com/role/IdentifiableintangibleassetsAdditionalInformationDetail">
        <link:definition>9955534 - Disclosure - Identifiable intangible assets - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillSummaryofChangesintheCarryingAmountofGoodwillbySegmentDetail" roleURI="http://www.tevapharm.com/role/GoodwillSummaryofChangesintheCarryingAmountofGoodwillbySegmentDetail">
        <link:definition>9955535 - Disclosure - Goodwill - Summary of Changes in the Carrying Amount of Goodwill by Segment (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillAdditionalInformationDetails" roleURI="http://www.tevapharm.com/role/GoodwillAdditionalInformationDetails">
        <link:definition>9955536 - Disclosure - Goodwill - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtobligationsScheduleofShorttermDebtDetail" roleURI="http://www.tevapharm.com/role/DebtobligationsScheduleofShorttermDebtDetail">
        <link:definition>9955537 - Disclosure - Debt obligations - Schedule of Short-term Debt (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtobligationsScheduleofLongtermDebtDetail" roleURI="http://www.tevapharm.com/role/DebtobligationsScheduleofLongtermDebtDetail">
        <link:definition>9955538 - Disclosure - Debt obligations - Schedule of Long-term Debt (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtobligationsAdditionalInformationDetail" roleURI="http://www.tevapharm.com/role/DebtobligationsAdditionalInformationDetail">
        <link:definition>9955539 - Disclosure - Debt obligations - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeinstrumentsandhedgingactivitiesAdditionalInformationDetail" roleURI="http://www.tevapharm.com/role/DerivativeinstrumentsandhedgingactivitiesAdditionalInformationDetail">
        <link:definition>9955540 - Disclosure - Derivative instruments and hedging activities - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeinstrumentsandhedgingactivitiesSummaryofClassificationandFairValuesofDerivativeInstrumentsDetail" roleURI="http://www.tevapharm.com/role/DerivativeinstrumentsandhedgingactivitiesSummaryofClassificationandFairValuesofDerivativeInstrumentsDetail">
        <link:definition>9955541 - Disclosure - Derivative instruments and hedging activities - Summary of Classification and Fair Values of Derivative Instruments (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeinstrumentsandhedgingactivitiesSummaryofClassificationandFairValuesofDerivativeInstrumentsDetail_1" roleURI="http://www.tevapharm.com/role/DerivativeinstrumentsandhedgingactivitiesSummaryofClassificationandFairValuesofDerivativeInstrumentsDetail_1">
        <link:definition>9955541 - Disclosure - Derivative instruments and hedging activities - Summary of Classification and Fair Values of Derivative Instruments (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeinstrumentsandhedgingactivitiesSummaryofPretaxGainsLossesFromDerivativesDesignatedinCashFlowHedgingRelationshipsDetail" roleURI="http://www.tevapharm.com/role/DerivativeinstrumentsandhedgingactivitiesSummaryofPretaxGainsLossesFromDerivativesDesignatedinCashFlowHedgingRelationshipsDetail">
        <link:definition>9955542 - Disclosure - Derivative instruments and hedging activities - Summary of Pre-tax (Gains) Losses From Derivatives Designated in Cash Flow Hedging Relationships (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeinstrumentsandhedgingactivitiesSummaryofPretaxGainsLossesFromDerivativesDesignatedinCashFlowHedgingRelationshipsDetail_1" roleURI="http://www.tevapharm.com/role/DerivativeinstrumentsandhedgingactivitiesSummaryofPretaxGainsLossesFromDerivativesDesignatedinCashFlowHedgingRelationshipsDetail_1">
        <link:definition>9955542 - Disclosure - Derivative instruments and hedging activities - Summary of Pre-tax (Gains) Losses From Derivatives Designated in Cash Flow Hedging Relationships (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeinstrumentsandhedgingactivitiesSummaryofPretaxGainsLossesFromDerivativesDesignatedinCashFlowHedgingRelationshipsDetail_2" roleURI="http://www.tevapharm.com/role/DerivativeinstrumentsandhedgingactivitiesSummaryofPretaxGainsLossesFromDerivativesDesignatedinCashFlowHedgingRelationshipsDetail_2">
        <link:definition>9955542 - Disclosure - Derivative instruments and hedging activities - Summary of Pre-tax (Gains) Losses From Derivatives Designated in Cash Flow Hedging Relationships (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeinstrumentsandhedgingactivitiesSummaryofPretaxGainsLossesFromDerivativesDesignatedinCashFlowHedgingRelationshipsDetail_3" roleURI="http://www.tevapharm.com/role/DerivativeinstrumentsandhedgingactivitiesSummaryofPretaxGainsLossesFromDerivativesDesignatedinCashFlowHedgingRelationshipsDetail_3">
        <link:definition>9955542 - Disclosure - Derivative instruments and hedging activities - Summary of Pre-tax (Gains) Losses From Derivatives Designated in Cash Flow Hedging Relationships (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeinstrumentsandhedgingactivitiesSummaryofPretaxGainsLossesFromDerivativesNotDesignatedinasHedgingInstrumentsDetail" roleURI="http://www.tevapharm.com/role/DerivativeinstrumentsandhedgingactivitiesSummaryofPretaxGainsLossesFromDerivativesNotDesignatedinasHedgingInstrumentsDetail">
        <link:definition>9955543 - Disclosure - Derivative instruments and hedging activities - Summary of Pre-tax (Gains) Losses From Derivatives Not Designated in as Hedging Instruments (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeinstrumentsandhedgingactivitiesSummaryofPretaxGainsLossesFromDerivativesNotDesignatedinasHedgingInstrumentsDetail_1" roleURI="http://www.tevapharm.com/role/DerivativeinstrumentsandhedgingactivitiesSummaryofPretaxGainsLossesFromDerivativesNotDesignatedinasHedgingInstrumentsDetail_1">
        <link:definition>9955543 - Disclosure - Derivative instruments and hedging activities - Summary of Pre-tax (Gains) Losses From Derivatives Not Designated in as Hedging Instruments (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LegalsettlementsandlosscontingenciesAdditionalInformationDetail" roleURI="http://www.tevapharm.com/role/LegalsettlementsandlosscontingenciesAdditionalInformationDetail">
        <link:definition>9955544 - Disclosure - Legal settlements and loss contingencies - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandcontingenciesPatentLitigationProductLiabilityLitigationandCompetitionMattersDetail" roleURI="http://www.tevapharm.com/role/CommitmentsandcontingenciesPatentLitigationProductLiabilityLitigationandCompetitionMattersDetail">
        <link:definition>9955545 - Disclosure - Commitments and contingencies - Patent Litigation, Product Liability Litigation and Competition Matters (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandcontingenciesGovernmentInvestigationsandLitigationRelatingtoPricingandMarketingDetails" roleURI="http://www.tevapharm.com/role/CommitmentsandcontingenciesGovernmentInvestigationsandLitigationRelatingtoPricingandMarketingDetails">
        <link:definition>9955546 - Disclosure - Commitments and contingencies - Government Investigations and Litigation Relating to Pricing and Marketing (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandcontingenciesOpioidsLitigationDetails" roleURI="http://www.tevapharm.com/role/CommitmentsandcontingenciesOpioidsLitigationDetails">
        <link:definition>9955547 - Disclosure - Commitments and contingencies - Opioids Litigation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandcontingenciesShareholderLitigationEnvironmentalMattersandGainContingenciesDetails" roleURI="http://www.tevapharm.com/role/CommitmentsandcontingenciesShareholderLitigationEnvironmentalMattersandGainContingenciesDetails">
        <link:definition>9955548 - Disclosure - Commitments and contingencies - Shareholder Litigation, Environmental Matters and Gain Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncometaxesAdditionalInformationDetail" roleURI="http://www.tevapharm.com/role/IncometaxesAdditionalInformationDetail">
        <link:definition>9955549 - Disclosure - Income taxes - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherassetsimpairmentsrestructuringandotheritemsScheduleofOtherAssetsImpairmentsRestructuringandOtherItemsDetail" roleURI="http://www.tevapharm.com/role/OtherassetsimpairmentsrestructuringandotheritemsScheduleofOtherAssetsImpairmentsRestructuringandOtherItemsDetail">
        <link:definition>9955550 - Disclosure - Other assets impairments, restructuring and other items - Schedule of Other Assets Impairments, Restructuring and Other Items (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherassetsimpairmentsrestructuringandotheritemsAdditionalInformationDetail" roleURI="http://www.tevapharm.com/role/OtherassetsimpairmentsrestructuringandotheritemsAdditionalInformationDetail">
        <link:definition>9955551 - Disclosure - Other assets impairments, restructuring and other items - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherassetsimpairmentsrestructuringandotheritemsComponentsofRestructuringCostsDetail" roleURI="http://www.tevapharm.com/role/OtherassetsimpairmentsrestructuringandotheritemsComponentsofRestructuringCostsDetail">
        <link:definition>9955552 - Disclosure - Other assets impairments, restructuring and other items - Components of Restructuring Costs (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherassetsimpairmentsrestructuringandotheritemsSummaryofRestructuringAccrualsDetail" roleURI="http://www.tevapharm.com/role/OtherassetsimpairmentsrestructuringandotheritemsSummaryofRestructuringAccrualsDetail">
        <link:definition>9955553 - Disclosure - Other assets impairments, restructuring and other items - Summary of Restructuring Accruals (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningslosspershareScheduleofEarningsperShareDetail" roleURI="http://www.tevapharm.com/role/EarningslosspershareScheduleofEarningsperShareDetail">
        <link:definition>9955554 - Disclosure - Earnings (loss) per share - Schedule of Earnings per Share (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningslosspershareAdditionalInformationDetail" roleURI="http://www.tevapharm.com/role/EarningslosspershareAdditionalInformationDetail">
        <link:definition>9955555 - Disclosure - Earnings (loss) per share - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedothercomprehensiveincomelossScheduleofAccumulatedOtherComprehensiveIncomeLossNetofTaxDetail" roleURI="http://www.tevapharm.com/role/AccumulatedothercomprehensiveincomelossScheduleofAccumulatedOtherComprehensiveIncomeLossNetofTaxDetail">
        <link:definition>9955556 - Disclosure - Accumulated other comprehensive income (loss) - Schedule of Accumulated Other Comprehensive Income/Loss Net of Tax (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedothercomprehensiveincomelossAdditionalInformationDetails" roleURI="http://www.tevapharm.com/role/AccumulatedothercomprehensiveincomelossAdditionalInformationDetails">
        <link:definition>9955557 - Disclosure - Accumulated other comprehensive income (loss) - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsAdditionalInformationDetail" roleURI="http://www.tevapharm.com/role/SegmentsAdditionalInformationDetail">
        <link:definition>9955558 - Disclosure - Segments - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsSummaryofSegmentProfitDetail" roleURI="http://www.tevapharm.com/role/SegmentsSummaryofSegmentProfitDetail">
        <link:definition>9955559 - Disclosure - Segments - Summary of Segment Profit (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsScheduleOfConsolidatedIncomeBeforeIncomeTaxDetails" roleURI="http://www.tevapharm.com/role/SegmentsScheduleOfConsolidatedIncomeBeforeIncomeTaxDetails">
        <link:definition>9955560 - Disclosure - Segments - Schedule Of Consolidated Income Before Income Tax (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsScheduleofRevenuesbyMajorProductsandActivitiesDetail" roleURI="http://www.tevapharm.com/role/SegmentsScheduleofRevenuesbyMajorProductsandActivitiesDetail">
        <link:definition>9955561 - Disclosure - Segments - Schedule of Revenues by Major Products and Activities (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairvaluemeasurementSummaryofFinancialItemsCarriedatFairValueDetail" roleURI="http://www.tevapharm.com/role/FairvaluemeasurementSummaryofFinancialItemsCarriedatFairValueDetail">
        <link:definition>9955562 - Disclosure - Fair value measurement - Summary of Financial Items Carried at Fair Value (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairvaluemeasurementAdditionalInformationDetail" roleURI="http://www.tevapharm.com/role/FairvaluemeasurementAdditionalInformationDetail">
        <link:definition>9955563 - Disclosure - Fair value measurement - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairvaluemeasurementSummaryofFairValueofFinancialLiabilitiesMeasuredUsingLevel3InputsDetail" roleURI="http://www.tevapharm.com/role/FairvaluemeasurementSummaryofFairValueofFinancialLiabilitiesMeasuredUsingLevel3InputsDetail">
        <link:definition>9955564 - Disclosure - Fair value measurement - Summary of Fair Value of Financial Liabilities Measured Using Level 3 Inputs (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairvaluemeasurementSummaryofFinancialInstrumentMeasuredonaBasisOtherThanFairValueDetail" roleURI="http://www.tevapharm.com/role/FairvaluemeasurementSummaryofFinancialInstrumentMeasuredonaBasisOtherThanFairValueDetail">
        <link:definition>9955565 - Disclosure - Fair value measurement - Summary of Financial Instrument Measured on a Basis Other Than Fair Value (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="teva_SalesReservesAndAllowances" abstract="false" name="SalesReservesAndAllowances" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_AccruedExpenses" abstract="false" name="AccruedExpenses" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_IntangibleAssetsImpairments" abstract="false" name="IntangibleAssetsImpairments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_ImpairmentsRestructuringAndOthers" abstract="false" name="ImpairmentsRestructuringAndOthers" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_LegalSettlementsAndLossContingencies" abstract="false" name="LegalSettlementsAndLossContingencies" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_UnrealizedGainLossOnDerivativeNetOfTax" abstract="false" name="UnrealizedGainLossOnDerivativeNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndMezzanineItems" abstract="false" name="NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndMezzanineItems" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_ImpairmentOfLongLivedAssetsAndAssetsHeldForSaleFiniteAndIndefiniteLivedIntangibleAssetsOtherThanGoodwill" abstract="false" name="ImpairmentOfLongLivedAssetsAndAssetsHeldForSaleFiniteAndIndefiniteLivedIntangibleAssetsOtherThanGoodwill" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_ResearchAndDevelopmentExpenseAndLiabilities" abstract="false" name="ResearchAndDevelopmentExpenseAndLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_DeferredIncomeTaxesNetAndUncertainTaxPositions" abstract="false" name="DeferredIncomeTaxesNetAndUncertainTaxPositions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_ProfitLossFromSaleOfLongLivedAssetsAndInvestment" abstract="false" name="ProfitLossFromSaleOfLongLivedAssetsAndInvestment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_ProceedsFromBeneficialInterestInExchangeForSecuritizedAccountsReceivables" abstract="false" name="ProceedsFromBeneficialInterestInExchangeForSecuritizedAccountsReceivables" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_ProceedsFromRepaymentsOfSeniorNotesNetOfIssuanceCosts" abstract="false" name="ProceedsFromRepaymentsOfSeniorNotesNetOfIssuanceCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_ProceedsFromPaymentSToMinorityNonControllingShareholders" abstract="false" name="ProceedsFromPaymentSToMinorityNonControllingShareholders" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_DividendsPaidToNonControllingInterests" abstract="false" name="DividendsPaidToNonControllingInterests" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_ReceivableForSaleOfLongLivedAssets" abstract="false" name="ReceivableForSaleOfLongLivedAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_IncreaseDecreaseInCertainCurrentAssetsExcludingInventories" abstract="false" name="IncreaseDecreaseInCertainCurrentAssetsExcludingInventories" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_CertainTransactionsDisclosureTextBlock" abstract="false" name="CertainTransactionsDisclosureTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="teva_RestructuringAndImpairmentAbstract" abstract="true" name="RestructuringAndImpairmentAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="teva_OtherExpensesTextBlock" abstract="false" name="OtherExpensesTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="teva_SalesReservesAndAllowancesCurrentTableTextBlock" abstract="false" name="SalesReservesAndAllowancesCurrentTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="teva_LongTermDebtExcludingConvertibleDebtTableTextBlock" abstract="false" name="LongTermDebtExcludingConvertibleDebtTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="teva_DisclosureInTabularFormOfPretaxGainLossCashFlowHedgingInstrumentsTableTextBlock" abstract="false" name="DisclosureInTabularFormOfPretaxGainLossCashFlowHedgingInstrumentsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="teva_ScheduleOfRestructuringChargesTableTextBlock" abstract="false" name="ScheduleOfRestructuringChargesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="teva_EmalexBiosciencesMember" abstract="true" name="EmalexBiosciencesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_FormerShareholdersMilestonePaymentMember" abstract="true" name="FormerShareholdersMilestonePaymentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_OtherThirdPartiesMilestonePaymentMember" abstract="true" name="OtherThirdPartiesMilestonePaymentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_AgreementMilestonePayments" abstract="false" name="AgreementMilestonePayments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_PercentageOfDiscountRateAppliedToTheCashFlows" abstract="false" name="PercentageOfDiscountRateAppliedToTheCashFlows" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="teva_CertainTransactionsLineItems" abstract="true" name="CertainTransactionsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="teva_AssetAcquisitionConsiderationTransferredCash" abstract="false" name="AssetAcquisitionConsiderationTransferredCash" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_AssetAcquisitionOtherCurrentAssets" abstract="false" name="AssetAcquisitionOtherCurrentAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_AssetAcquisitionDeferredIncomeTaxes" abstract="false" name="AssetAcquisitionDeferredIncomeTaxes" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_AssetAcquisitionValuationAllowance" abstract="false" name="AssetAcquisitionValuationAllowance" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_AssetAcquisitionAccruedExpenses" abstract="false" name="AssetAcquisitionAccruedExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_AssetAcquisitionOtherLiabilities" abstract="false" name="AssetAcquisitionOtherLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_AssetAcquisitionIdentifiableAssetsAndLiabilitiesAcquiredNet" abstract="false" name="AssetAcquisitionIdentifiableAssetsAndLiabilitiesAcquiredNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_AssetAcquisitionAcquiredInProcessResearchAndDevelopmentAssets" abstract="false" name="AssetAcquisitionAcquiredInProcessResearchAndDevelopmentAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_PolpharmaBiologicsInternationalAGMember" abstract="true" name="PolpharmaBiologicsInternationalAGMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_BlackstoneLifeSciencesMember" abstract="true" name="BlackstoneLifeSciencesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_MabxienceMember" abstract="true" name="MabxienceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_AbingworthMember" abstract="true" name="AbingworthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_BiolojicDesignLtdMember" abstract="true" name="BiolojicDesignLtdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_RoyaltyPharmaMember" abstract="true" name="RoyaltyPharmaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_ModagMember" abstract="true" name="ModagMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_AlvotechMember" abstract="true" name="AlvotechMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_MedincellMember" abstract="true" name="MedincellMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_SamsungBioepisMember" abstract="true" name="SamsungBioepisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_SanofiMember" abstract="true" name="SanofiMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_BioXcelTherapeuticsMember" abstract="true" name="BioXcelTherapeuticsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_NumberOfCandidates" abstract="false" name="NumberOfCandidates" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="teva_MilestonePayment" abstract="false" name="MilestonePayment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_NumberOfAdditionalCandidates" abstract="false" name="NumberOfAdditionalCandidates" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="teva_MilestonePaymentAggregateCapPerCompany" abstract="false" name="MilestonePaymentAggregateCapPerCompany" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_LicenseAgreementPotentialAggregateMilestonePaymentsAmount" abstract="false" name="LicenseAgreementPotentialAggregateMilestonePaymentsAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_NumberOfCandidatesWithLineExtensions" abstract="false" name="NumberOfCandidatesWithLineExtensions" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="teva_CollaborativeAgreementMilestonePayments" abstract="false" name="CollaborativeAgreementMilestonePayments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_CollaborativeAgreementMilestonePaymentsPeriod" abstract="false" name="CollaborativeAgreementMilestonePaymentsPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="teva_AggregateUpfrontAndMilestonePayments" abstract="false" name="AggregateUpfrontAndMilestonePayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_IncreaseInDevelopmentFundingCommitment" abstract="false" name="IncreaseInDevelopmentFundingCommitment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_CollaborationPartnerFundingReimbursements" abstract="false" name="CollaborationPartnerFundingReimbursements" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_AdditionalDevelopmentAndMilestonePaymentsReceivable" abstract="false" name="AdditionalDevelopmentAndMilestonePaymentsReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_Phase2bfundingoptionamount" abstract="false" name="Phase2bfundingoptionamount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_Phase3fundingoptionamount" abstract="false" name="Phase3fundingoptionamount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_MilestonePaymentPercentageCap" abstract="false" name="MilestonePaymentPercentageCap" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="teva_MilestonePaymentReceivable" abstract="false" name="MilestonePaymentReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_MilestonePaymentPaymentOne" abstract="false" name="MilestonePaymentPaymentOne" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_MilestonePaymentPaymentTwo" abstract="false" name="MilestonePaymentPaymentTwo" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_DevelopmentAndLaunchMilestonePaymentReceivable" abstract="false" name="DevelopmentAndLaunchMilestonePaymentReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_MilestonePaymentToBePaid" abstract="false" name="MilestonePaymentToBePaid" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_TevaAPIBusinessMember" abstract="true" name="TevaAPIBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_ExpectedLossFromReclassificationOfCurrencyTranslationAdjustments" abstract="false" name="ExpectedLossFromReclassificationOfCurrencyTranslationAdjustments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_UnitedStatesSegmentMember" abstract="true" name="UnitedStatesSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_EuropeSegmentMember" abstract="true" name="EuropeSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_InternationalMarketsMember" abstract="true" name="InternationalMarketsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_RevenueRecognitionLineItems" abstract="true" name="RevenueRecognitionLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="teva_SalesReservesAndAllowancesToCustomersPercentage" abstract="false" name="SalesReservesAndAllowancesToCustomersPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="teva_ReservesIncludedInAccountsReceivableNetMember" abstract="true" name="ReservesIncludedInAccountsReceivableNetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_TotalReservesIncludedInSalesReservesAndAllowancesMember" abstract="true" name="TotalReservesIncludedInSalesReservesAndAllowancesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_RebatesMember" abstract="true" name="RebatesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_MedicaidAndOtherGovernmentalAllowancesMember" abstract="true" name="MedicaidAndOtherGovernmentalAllowancesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_ChargebacksMember" abstract="true" name="ChargebacksMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_ReturnsMember" abstract="true" name="ReturnsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_OtherSalesReservesAndAllowancesMember" abstract="true" name="OtherSalesReservesAndAllowancesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_ValuationAllowancesAndReservesRelatedToCurrentPeriodSales" abstract="false" name="ValuationAllowancesAndReservesRelatedToCurrentPeriodSales" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_ValuationAllowancesAndReservesRelatedToPriorPeriodSales" abstract="false" name="ValuationAllowancesAndReservesRelatedToPriorPeriodSales" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_ValuationAllowancesAndReservesForeignCurrencyTranslation" abstract="false" name="ValuationAllowancesAndReservesForeignCurrencyTranslation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_ProductRightsMember" abstract="true" name="ProductRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_EventBasisAxis" abstract="true" name="EventBasisAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="teva_EventBasisDomain" abstract="true" name="EventBasisDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_UpdatedMarketAssumptionsMember" abstract="true" name="UpdatedMarketAssumptionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_RegulatoryPriceAndVolumeOfProductsMember" abstract="true" name="RegulatoryPriceAndVolumeOfProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_DevelopmentProgressAndChangesInOtherKeyValuationAssumptionsMember" abstract="true" name="DevelopmentProgressAndChangesInOtherKeyValuationAssumptionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_GenericPipelineProductsMember" abstract="true" name="GenericPipelineProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_ShortCreditAgreement2026Member" abstract="true" name="ShortCreditAgreement2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_DebtInstrumentMaturityYear" abstract="false" name="DebtInstrumentMaturityYear" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:gYearItemType"/>
  <xs:element id="teva_SubsidiarySeniorNotesDue2026Member" abstract="true" name="SubsidiarySeniorNotesDue2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_SubsidiarySeniorNotesDue2027Member" abstract="true" name="SubsidiarySeniorNotesDue2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_SustainabilityLinkedSeniorNotesDue2027Member" abstract="true" name="SustainabilityLinkedSeniorNotesDue2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_SustainabilityLinkedSeniorNotesDue2027OneMember" abstract="true" name="SustainabilityLinkedSeniorNotesDue2027OneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_SubsidiarySeniorNotesDue2028Member" abstract="true" name="SubsidiarySeniorNotesDue2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_SubsidiarySeniorNotesDue2028OneMember" abstract="true" name="SubsidiarySeniorNotesDue2028OneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_SustainabilityLinkedSeniorNotesDue2029Member" abstract="true" name="SustainabilityLinkedSeniorNotesDue2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_SustainabilityLinkedSeniorNotesDue2029OneMember" abstract="true" name="SustainabilityLinkedSeniorNotesDue2029OneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_SustainabilityLinkedSeniorNotesDue2029TwoMember" abstract="true" name="SustainabilityLinkedSeniorNotesDue2029TwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_SustainabilityLinkedSeniorNotesDue2030Member" abstract="true" name="SustainabilityLinkedSeniorNotesDue2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_SeniorNotesUSD700MillionMember" abstract="true" name="SeniorNotesUSD700MillionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_SustainabilityLinkedSeniorNotesDue2031Member" abstract="true" name="SustainabilityLinkedSeniorNotesDue2031Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_SustainabilityLinkedSeniorNotesDue2031OneMember" abstract="true" name="SustainabilityLinkedSeniorNotesDue2031OneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_SeniorNotesEUR1000MillionDue2031Member" abstract="true" name="SeniorNotesEUR1000MillionDue2031Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_SeniorNotesUSD500MillionMember" abstract="true" name="SeniorNotesUSD500MillionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_SeniorNotesUSD1200MillionDue2032Member" abstract="true" name="SeniorNotesUSD1200MillionDue2032Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_SeniorNotesEUR1000MillionDue2033Member" abstract="true" name="SeniorNotesEUR1000MillionDue2033Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_SeniorNotesUSD1000MillionDue2034Member" abstract="true" name="SeniorNotesUSD1000MillionDue2034Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_SubsidiarySeniorNotesUSD789MillionDue2036Member" abstract="true" name="SubsidiarySeniorNotesUSD789MillionDue2036Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_SeniorNotesEUR500MillionDue2036Member" abstract="true" name="SeniorNotesEUR500MillionDue2036Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_SeniorNotesUSD1000MillionDue2037Member" abstract="true" name="SeniorNotesUSD1000MillionDue2037Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_SubsidiarySeniorNotesDue2046Member" abstract="true" name="SubsidiarySeniorNotesDue2046Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_AmendedRevolvingCreditFacilityMember" abstract="true" name="AmendedRevolvingCreditFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_LongTermDebtCurrencyPortionUSD" abstract="false" name="LongTermDebtCurrencyPortionUSD" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="teva_LeverageRatio" abstract="false" name="LeverageRatio" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:decimalItemType"/>
  <xs:element id="teva_AccountsReceivableSecuritizationFacilityMember" abstract="true" name="AccountsReceivableSecuritizationFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_FactoringInstitutionAxis" abstract="true" name="FactoringInstitutionAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="teva_FactoringInstitutionDomain" abstract="true" name="FactoringInstitutionDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_BNPParibasBankMember" abstract="true" name="BNPParibasBankMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_PncBankMember" abstract="true" name="PncBankMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_FacilityAxis" abstract="true" name="FacilityAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="teva_FacilityDomain" abstract="true" name="FacilityDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_InitialCommitmentMember" abstract="true" name="InitialCommitmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_AgreementAxis" abstract="true" name="AgreementAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="teva_AgreementDomain" abstract="true" name="AgreementDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_SPVAmendmentAgreementOctoberTwoThousandAndTwentyFourMember" abstract="true" name="SPVAmendmentAgreementOctoberTwoThousandAndTwentyFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_PeriodAxis" abstract="true" name="PeriodAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="teva_PeriodDomain" abstract="true" name="PeriodDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_NovemberTwoThousandAndTwentyThreeMember" abstract="true" name="NovemberTwoThousandAndTwentyThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_RevenuesOtherThanUsd" abstract="false" name="RevenuesOtherThanUsd" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="teva_TransactionsTerminationLossSettled" abstract="false" name="TransactionsTerminationLossSettled" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_ForwardStartingInterestRateSwapsAndTreasuryLockAgreementsLosses" abstract="false" name="ForwardStartingInterestRateSwapsAndTreasuryLockAgreementsLosses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_CrossCurrencySwapCashFlowHedgeMember" abstract="true" name="CrossCurrencySwapCashFlowHedgeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_UnrealizedGainLossOnCashFlowHedgingInstrument" abstract="false" name="UnrealizedGainLossOnCashFlowHedgingInstrument" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_FivePointTwoFiveSeniorNotesDue2032Member" abstract="true" name="FivePointTwoFiveSeniorNotesDue2032Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_FivePointSevenFiveSeniorNotesDue2030Member" abstract="true" name="FivePointSevenFiveSeniorNotesDue2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_ValsartanMember" abstract="true" name="ValsartanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_ParagardMember" abstract="true" name="ParagardMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_VenlafaxineMember" abstract="true" name="VenlafaxineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_EffexorMember" abstract="true" name="EffexorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_LamictalMember" abstract="true" name="LamictalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_NiaspanMember" abstract="true" name="NiaspanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_TruvadaMember" abstract="true" name="TruvadaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_AtriplaMember" abstract="true" name="AtriplaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_COPAXONEMember" abstract="true" name="COPAXONEMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_RevlimidMember" abstract="true" name="RevlimidMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_NuvigilMember" abstract="true" name="NuvigilMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_XifaxanMember" abstract="true" name="XifaxanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_ClassesOfDirectPurchaserPlaintiffsFiledClaims" abstract="false" name="ClassesOfDirectPurchaserPlaintiffsFiledClaims" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="teva_AnnualSales" abstract="false" name="AnnualSales" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_LitigationFineAmount" abstract="false" name="LitigationFineAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_EuropeanCommissionSuretyUnderwrittenGuarantees" abstract="false" name="EuropeanCommissionSuretyUnderwrittenGuarantees" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_NumberOfCompetitionAndMarketsAuthorityInvestigations" abstract="false" name="NumberOfCompetitionAndMarketsAuthorityInvestigations" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="teva_NumberOfCompetitionAndMarketsAuthorityInvestigationsAgreedToIndemnity" abstract="false" name="NumberOfCompetitionAndMarketsAuthorityInvestigationsAgreedToIndemnity" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="teva_DeferredProsecutionAgreementWithU.s.DepartmentOfJusticeMember" abstract="true" name="DeferredProsecutionAgreementWithU.s.DepartmentOfJusticeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_DonationOfClotrimazoleAndTobramycinMember" abstract="true" name="DonationOfClotrimazoleAndTobramycinMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_FineForViolatingTheAntitrustLawsMember" abstract="true" name="FineForViolatingTheAntitrustLawsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_CivilInvestigativeDemandFromDepartmentOfJusticeCivilDivisionMember" abstract="true" name="CivilInvestigativeDemandFromDepartmentOfJusticeCivilDivisionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_CivilActionInRespectOfDonationsToPatientAssistanceProgrammersMember" abstract="true" name="CivilActionInRespectOfDonationsToPatientAssistanceProgrammersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_TwoThousandAndTwentyFourMember" abstract="true" name="TwoThousandAndTwentyFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_TwoThousandAndTwentyFiveMember" abstract="true" name="TwoThousandAndTwentyFiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_LossContingencyNumberOfIndictmentCharges" abstract="false" name="LossContingencyNumberOfIndictmentCharges" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="teva_LossContingencyNumberOfInstances" abstract="false" name="LossContingencyNumberOfInstances" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="teva_LossContingencyNumberOfCustomersInvolved" abstract="false" name="LossContingencyNumberOfCustomersInvolved" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="teva_OtherCommitmentToPayForEachYear" abstract="false" name="OtherCommitmentToPayForEachYear" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_LossContingencyAttorneysGeneralLawsuits" abstract="false" name="LossContingencyAttorneysGeneralLawsuits" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="teva_LossContingencyClaimsDismissedValuePaidToEachStateProportionalToItsShareOfNationalPopulation" abstract="false" name="LossContingencyClaimsDismissedValuePaidToEachStateProportionalToItsShareOfNationalPopulation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_PercentageOfShareOfTheNationalPopulation" abstract="false" name="PercentageOfShareOfTheNationalPopulation" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="teva_CasesOfDirectPurchaserPlaintiffs" abstract="false" name="CasesOfDirectPurchaserPlaintiffs" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="teva_LossContingencyAccrualRemainderOfFiscalYear" abstract="false" name="LossContingencyAccrualRemainderOfFiscalYear" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_LossContingencyAccrualNextTwelveMonths" abstract="false" name="LossContingencyAccrualNextTwelveMonths" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_LossContingencyAccrualDueInYearThree" abstract="false" name="LossContingencyAccrualDueInYearThree" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_LossContingencyAccrualDueInFourthYear" abstract="false" name="LossContingencyAccrualDueInFourthYear" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_LossContingencyAccrualDueInFifthYear" abstract="false" name="LossContingencyAccrualDueInFifthYear" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_OpioidLitigationMember" abstract="true" name="OpioidLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_OpioidLitigationAndaMember" abstract="true" name="OpioidLitigationAndaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_ModafinilSettlementAgreementMember" abstract="true" name="ModafinilSettlementAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_LossContingencyNumberOfComplaints" abstract="false" name="LossContingencyNumberOfComplaints" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="teva_LitigationSettlementAmountAwardedDistributionPeriod" abstract="false" name="LitigationSettlementAmountAwardedDistributionPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="teva_LitigationSettlementAmountDistributableinKind" abstract="false" name="LitigationSettlementAmountDistributableinKind" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_LitigationSettlementAmountPayableInCashPercentage" abstract="false" name="LitigationSettlementAmountPayableInCashPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="teva_LitigationSettlementAmountDistributableInCash" abstract="false" name="LitigationSettlementAmountDistributableInCash" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_SettlementAsAPercentageOfAggregateSubdivisionsAndTribes" abstract="false" name="SettlementAsAPercentageOfAggregateSubdivisionsAndTribes" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="teva_LossContingencyAggregatePaymentsPaid" abstract="false" name="LossContingencyAggregatePaymentsPaid" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_OntarioTeachersSecuritiesLitigationMember" abstract="true" name="OntarioTeachersSecuritiesLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_LillyGalcanezumabProductMember" abstract="true" name="LillyGalcanezumabProductMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_LillyGalcanezumabProductMethodOfTreatmentPatentMember" abstract="true" name="LillyGalcanezumabProductMethodOfTreatmentPatentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_LillyGalcanezumabProductCompositionOfMatterPatentMember" abstract="true" name="LillyGalcanezumabProductCompositionOfMatterPatentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_AmarinVascepaDrugMember" abstract="true" name="AmarinVascepaDrugMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_EliLillyMember" abstract="true" name="EliLillyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_LossContingenciesOnEnvironmentalLawsPenalty" abstract="false" name="LossContingenciesOnEnvironmentalLawsPenalty" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_IncomeTaxTable" abstract="true" name="IncomeTaxTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="teva_TwoThousandEightThroughTaxPayableMember" abstract="true" name="TwoThousandEightThroughTaxPayableMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_IncomeTaxLineItems" abstract="true" name="IncomeTaxLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="teva_NumberOfYearsSpreadToPayTaxPayable" abstract="false" name="NumberOfYearsSpreadToPayTaxPayable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="teva_MaximumTaxPaymentLimit" abstract="false" name="MaximumTaxPaymentLimit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_MinimumTaxRate" abstract="false" name="MinimumTaxRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="teva_LegalSettlementsLossContingenciesImpairmentsOtherExpenses" abstract="false" name="LegalSettlementsLossContingenciesImpairmentsOtherExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_ImpairmentAndRestructuring" abstract="false" name="ImpairmentAndRestructuring" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminatedPercent" abstract="false" name="RestructuringAndRelatedCostExpectedNumberOfPositionsEliminatedPercent" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="teva_ExitAndDisposalAxis" abstract="true" name="ExitAndDisposalAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="teva_ExitAndDisposalDomain" abstract="true" name="ExitAndDisposalDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_EmployeeTerminationMember" abstract="true" name="EmployeeTerminationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_OtherExitAndDisposalMember" abstract="true" name="OtherExitAndDisposalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_RestructuringAccrualProvision" abstract="false" name="RestructuringAccrualProvision" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_UtilizationAndOther" abstract="false" name="UtilizationAndOther" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_ReleaseFromAccumulatedOtherComprehensiveIncomeOfCumulativeTranslationAdjustmentsBeforeTax" abstract="false" name="ReleaseFromAccumulatedOtherComprehensiveIncomeOfCumulativeTranslationAdjustmentsBeforeTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_AmericanDepositarySharesToOrdinarySharesConversionRatio" abstract="false" name="AmericanDepositarySharesToOrdinarySharesConversionRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:decimalItemType"/>
  <xs:element id="teva_IntangibleAssetImpairments" abstract="false" name="IntangibleAssetImpairments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_LegalSettlementsAndLossContingenciesUnallocatedToSegments" abstract="false" name="LegalSettlementsAndLossContingenciesUnallocatedToSegments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_GenericsMediciansIncludingOtcAndBiosimilarsMember" abstract="true" name="GenericsMediciansIncludingOtcAndBiosimilarsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_AjovyMember" abstract="true" name="AjovyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_AustedoMember" abstract="true" name="AustedoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_BendekaAndTreandaMember" abstract="true" name="BendekaAndTreandaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_UzedyMember" abstract="true" name="UzedyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_RespiratoryProductMember" abstract="true" name="RespiratoryProductMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_OtherProductsMember" abstract="true" name="OtherProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_CashDepositsAndOtherMember" abstract="true" name="CashDepositsAndOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_OtherMember" abstract="true" name="OtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_BusinessCombinationContingentConsiderationLiabilityMeasurementInputChange" abstract="false" name="BusinessCombinationContingentConsiderationLiabilityMeasurementInputChange" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="teva_AllerganTransactionMember" abstract="true" name="AllerganTransactionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_EagleTransactionMember" abstract="true" name="EagleTransactionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_NoveTideAcquisitionMember" abstract="true" name="NoveTideAcquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationProvisionAdjustments" abstract="false" name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationProvisionAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="teva_SeniorNotesAndSustainabilityLinkedSeniorNotesMember" abstract="true" name="SeniorNotesAndSustainabilityLinkedSeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_SeniorNotesAndConvertibleSeniorDebenturesMember" abstract="true" name="SeniorNotesAndConvertibleSeniorDebenturesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_ChristineFoxMember" abstract="true" name="ChristineFoxMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_MatthewShieldsMember" abstract="true" name="MatthewShieldsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="teva_Dr.EricHughesMember" abstract="true" name="Dr.EricHughesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
